Estimates of antibiotic resistance in Italy and Western Europe in 2019: a comparative analysis based on MICROBE
By 2050, it is estimated that antimicrobial resistance (AMR) will cause 10 million annual deaths worldwide, costing up to $100 trillion. Antibiotic resistance (ABR) is the most significant health threat and, in 2019, caused 1.27 million deaths globally. One in 5 deaths occurred under five years of...
The Burden of Type 1 and 2 Diabetes among adolescents and young adults in 24 Western European countries, 1990-2019
As little is known about the burden of type 1 (T1DM) and type 2 diabetes (T2DM) in adolescents in Western Europe (WE), we aimed to explore their epidemiology among 10-24 year-olds. Estimates were retrieved from the Global Burden of Diseases Study (GBD) 2019. We reported counts, rates per 100,000...
Measures of the burden of type 2 diabetes in Italy assessed using AMD data over 12 years
Patients with type 2 diabetes mellitus (T2DM) are rapidly increasing in Italy due to aging, preventable risk factors, and a worsening socioeconomic environment. T2DM and its consequences take a heavy toll on health care systems and the economy, given the costly management, difficulties in coping...
WHO WE ARE.
The Italian Global Burden of Disease Initiative, or Italian GBD Initiative, is an Italian network of researchers actively contributing to the project Global Burden of Disease Study, GBD.
To date, more than 150 collaborators from more than 25 research institutions are part of the Italian GBD Initiative.